Volitionrx VNRX
NYSE VNRX
$0.26 +0.00 (+0.47%)
As of: Sep 30, 2026 · 3:32 PM EDT

Volitionrx (VNRX) Convertible Debt (2025 - 2026)

Updated

Volitionrx (VNRX) posted Convertible Debt of $239,807 for Q2 2026, down 91.8% from $2.92 million a year earlier.

Analysis

Volitionrx (VNRX) Convertible Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Volitionrx's Convertible Debt came in at $1.44 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 Volitionrx 1.02 Mn -6.71 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 239,807.00
Dec 31, 2025 1.44 Mn
Sep 30, 2025 2.26 Mn
Jun 30, 2025 2.92 Mn
API Access

Volitionrx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=VNRX&period=max&api_key=YOUR_API_KEY